John M, Williams L, Nolan G, Bonnett M, et al. Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS). HIV Med 2024 Apr 21. doi: 10.1111/hiv.13647.
PMID: 38644518